Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...

Novavax’s CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a recent ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

MIAMI--(BUSINESS WIRE)--As the marketing landscape has grown more complex and the number of tools required to manage marketing activities increases, organizations are prioritizing integration and ...

Novavax (NASDAQ:NVAX) shares climbed about 5% on Tuesday after the biotech group disclosed a non-exclusive licensing ...

The agreement allows Pfizer to utilize Novavax’s Matrix-M adjuvant in up to two disease areas with its products. Under the ...

DG Matrix announces the first field deployment of its breakthrough Power Router technology to accelerate global electrification and alleviate grid constraints. In a bold move to leapfrog the entire ...

The addition to its KVM matrix portfolio brings enterprise-grade KVM capabilities to more streamlined applications with a ‘plug and play’ architecture When you purchase through links on our site, we ...